COSCIENS Biopharma Overview
Latest P/E ratio for COSCIENS Biopharma: -0.42 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-0.42
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, CSCI shows a P/E ratio of -0.42. That is below the sector sector average of 34.88. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 34.88. COSCIENS Biopharma is at -0.42, which is lower that average. That is roughly 101.2% below the sector mean. Use the comparison chart on this page to see how CSCI stacks up against individual peers as well.
Investors watch CSCI's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. COSCIENS Biopharma's latest reading is -0.42. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has COSCIENS Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -0.42) with ownership activity and broader fundamentals.
